Artemether 20 mg / lumefantrine 120 mg Oral Tablet
RxNorm 847731
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 847731 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: artemether 20 mg / lumefantrine 120 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Artemether 20 mg / lumefantrine 120 mg Oral Tablet
(Atom ID: 2966907)
PSNPrescribable
Prescribable Name (PSN):
Artemether 20 mg / lumefantrine 120 mg Oral Tablet
(Atom ID: 6364245)
PTPrescribable
Designated preferred name (PT):
Artemether 20 mg and lumefantrine 120 mg oral tablet
(Atom ID: 9248839)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely artemether 20 mg and lumefantrine 120 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10309387)
Patient Education
Artemether and Lumefantrine
The combination of artemether and lumefantrine is used to treat certain kinds of malaria infections (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death). Artemether and lumefantrine should not be used to prevent malaria. Artemether and lumefantrine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
[Learn More]
* Please review the disclaimer below.